Trial intelligence / Profile preview

Medication Facilitated Ureteral Access Sheath Deployment

NCT03229889Phase 4Completed

Sponsor
University of California, Irvine
Start
Jun 2017
Primary completion
Mar 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of tadalafil, tamsulosin in nephrolithiasis, sponsored by University of California, Irvine. Started Jun 2017; status: completed.

02

Drugs

tadalafiltamsulosin
03

Conditions

nephrolithiasis

Beyond the preview

Go deeper on NCT03229889.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03229889.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call